Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001234954 | SCV001407616 | uncertain significance | Congenital myasthenic syndrome 4A | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with serine at codon 340 of the CHRNE protein (p.Pro340Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002504321 | SCV002815173 | uncertain significance | Congenital myasthenic syndrome 4A; Congenital myasthenic syndrome 4C; Congenital myasthenic syndrome 4B | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834036 | SCV002093399 | uncertain significance | Congenital myasthenic syndrome | 2021-06-29 | no assertion criteria provided | clinical testing |